Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com MT. LAUREL, N.J., Sept. 16, 2025 (GLOBE NEWSWIRE) — United Health Products (OTCQB: UEEC), focused on the development and commercialization of innovative wound care technologies, today announced that Brian Thom, Chief Executive Officer, will present live at the Life Sciences […]
Press Releases
United Health Products Provides Regulatory Status Update
Mount Laurel, New Jersey – July 31, 2025 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussions with the Food & Drug Administration. As previously disclosed, the Company’s Investigational Device Exemption (IDE) application was disallowed pending resolution of the FDA Warning Letter issued on March 25, 2025, identifying certain violations […]
United Health Products Provides Regulatory Application Update
Mount Laurel, New Jersey – June 6, 2025 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussion with the Food & Drug Administration. As previously disclosed, the review by FDA’s Office of Product Evaluation and Quality of its Investigational Device Exemption (IDE) application to conduct the follow-on clinical study of […]
United Health Products Announces OTCQB Uplisting and FDA Update
Mount Laurel, New Jersey – May 1, 2025 – United Health Products, Inc. (OTCQB: UEEC) is pleased to announce that it has been approved to have its common shares uplisted from the OTC “Pink” market to the OTCQB Venture Market (“OTCQB”). The successful uplisting is effective May 1, 2025 and the company’s common shares will continue […]
United Health Products Provides Update on FDA and OTC Markets Applications
Mount Laurel, New Jersey – March 28, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities. As previously disclosed, the FDA requested that certain additional sterilization and biocompatibility tests be included in the company’s Investigational Device Exemption (IDE) application. An IDE approval is a […]
United Health Products Provides Update on Capital Markets and Regulatory Processes
Mount Laurel, New Jersey – March 13, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities. As previously disclosed, UHP has submitted an application to OTC Markets to have its common shares quoted on the OTCQB market, which the company believes will increase the […]